Power Morcellator Lawsuit Surge Sparks Creation Of MDL

Tracey & Fox reports that as lawsuits against various power morcellator manufacturers continue to increase and add up, the federal judicial panel has coordinated over two dozen to form Multidistrict Litigation (or MDL). The lawsuits which have been consolidated all similarly allege that the power morcellator device, used during gynecological surgeries, is causing women to develop aggressive and widespread cancers.

It was noted by the United States Judicial Panel for Multidistrict Litigation that power morcellator lawsuits were likely to continue to appear due to the fact that 650,000 women have hysterectomies or myomectomies yearly due to uterine fibroids, and some of these procedures will be completed by using a power morcellator.

In the current consolidated cases, allegations state that a power morcellator which removed uterine tissue or fibroids during a hysterectomy subsequently led to cancer. The device, which is inserted into the abdomen through a small incision, works much like a drill to tear up tissue that is causing problems. The concern is, however, that as this tissue is torn up and spread throughout the abdominal cavity, it uncovers previously undetected cancer cells and spreads them as well. These cells then allegedly cause aggressive and widespread cancer, and therefore are a significant danger to the lifespan of the patient.

Lawsuits filed are against various manufacturers. Manufacturer Ethicon Inc. has since completely discontinued the production of their power morcellators, and has recalled those which were already sold to hospitals. As of the 15th of October of this year, Ethicon faced 22 lawsuits in federal court concerning their morcellator tools.

The United States Food and Drug Administration has warned that it is likely that 1 out of every 350 women undergoing power morcellation procedures to remove benign uterine fibroids in fact have previously undetected cancer, specifically uterine sarcoma. By using the morcellator tool on this area, it can stir up and spread that cancerous tissue and significantly impact their likelihood of survival.

In addition to this warning, the FDA also made note that women undergoing gynecological surgeries such as hysterectomies and myomectomies should not use power morcellator tools. At this time, because there is no way to determine whether or not a patient’s fibroids are cancerous or benign, the tool seems to pose too great of a risk. Although the power morcellator technique is the most non-invasive, there are other surgical options available which may be safer, despite their longer recovery times. The FDA asked all power morcellator manufacturers to increase the information on their warning labels to better indicate the risks associated with the tool.

The morcellation litigation team at Tracey & Fox Law is currently working to ensure that anyone who has undergone a power morcellation procedure and was subsequently diagnosed with widespread or aggressive cancer can explore their legal rights. These individuals may be entitled to compensation. Tracey & Fox is providing free consultations regarding power morcellation at this time.

For additional information concerning power morcellation or the risks associated with this procedure, or to ask questions, please contact Tracey & Fox by calling 713-322-5375 at your convenience.

###

Contact Tracey & Fox:

Sean Tracey
713-495-2333
440 Louisiana Street , Suite 1901 Houston, TX 77002

FacebookTwitterGoogleDiggRedditLinkedIn

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.